This article was originally published in The Tan Sheet
Supplement/OTC drug manufacturer reaches agreement in principle with lenders to extend forbearance deadline until Sept. 28. Extension enables company to continue push toward permanent financial restructuring plan (1"The Tan Sheet" Aug. 20, p. 9)
You may also be interested in...
Leiner Health Products' ongoing restructuring efforts appear to be paying dividends as the firm's net sales jumped 7.2% to $139.5 mil. for the first quarter ended June 30.
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning